John Green, 33-Year-Old Caucasian Male Presents To The Offic
John Green 33 Year Old Caucasian Male Presents To The Office To Esta
John Green, a 33-year-old Caucasian male, presents to the office to establish care as a new patient. His natal sex is female, but he identifies as male, having transitioned from female to male two years ago with social and family support completed last year. He recently moved back home and is currently unemployed. He has been self-administering testosterone obtained via the internet and has only recently engaged with healthcare providers for suppression medications through telehealth, three months prior.
His medical history includes a significant smoking history of two packs per day for ten years and regular marijuana use, consuming three to six joints every weekend, with an active green card. He also reports episodes of depression. HIV-positive status has been ongoing for three years; he remains virally suppressed as of his last lab draw six months ago. He reports feeling very weak over the past few weeks, which precipitated his return to his parental home. His current medications include Biktarvy, taken once daily for HIV management, which he tolerates well, and 100 mg of testosterone administered intramuscularly every week.
His past medical history is non-contributory with no prior significant illnesses. He has never been married and reports no significant family medical history. He expresses concern regarding his recent unemployment, living situation, and perceived health decline and worries about becoming a burden on his family.
Paper For Above instruction
Introduction
The healthcare management of transgender individuals, especially those who self-administer hormone therapy and face social vulnerabilities, presents unique challenges and opportunities for healthcare providers. Understanding the complex interplay of hormonal therapy, mental health, substance use, HIV management, and social determinants of health is crucial for delivering comprehensive, patient-centered care. This paper discusses the case of John Green, a transgender man with multiple health considerations, exploring holistic management strategies tailored to his needs.
Understanding the Patient’s Background and Healthcare Needs
John’s history of gender transition highlights the importance of gender-affirming care in improving mental health and overall well-being. His self-administered testosterone, bypassing healthcare oversight, raises concerns about potential side effects or adverse events due to unmonitored therapy. Access to healthcare should be simplified, emphasizing safe hormone management, monitoring, and supportive counseling. Additionally, his recent weakness warrants thorough evaluation to detect underlying causes, including anemia, nutritional deficiencies, or effects related to hormone therapy or HIV.
Managing Hormonal Therapy and Monitoring
Given that John has been self-administering testosterone, a primary step involves establishing a safe, monitored testosterone therapy plan. Regular monitoring of testosterone levels, hematocrit/hemoglobin, liver function, lipid profile, and screening for erythrocytosis is essential. Adjustments to dose may be necessary to avoid complications such as polycythemia, which can increase thromboembolic risk. Since he has only recently engaged with healthcare, provider-led education about hormone therapy, risks, and signs of adverse effects are critical.
Addressing Mental Health and Substance Use
John reports episodes of depression, which require evaluation and management. Mental health support, including counseling or psychiatric referral, should be integrated into his care, considering the psychosocial stressors related to unemployment, social reintegration, and health concerns. His substance use—smoking and marijuana consumption—also merits discussion, as both can impact overall health, HIV management, and mental health. Smoking cessation strategies and harm reduction approaches should be encouraged.
HIV Management and Ongoing Care
John’s HIV infection is well-controlled with Biktarvy, which he tolerates without issues. Continuity of antiretroviral therapy (ART) remains essential, and monitoring for potential drug interactions with testosterone and other substances should be performed. Regular follow-up for viral suppression, CD4 counts, and screening for opportunistic infections is vital, especially given his recent health decline.
Addressing Social and Economic Determinants of Health
His recent unemployment and living situation impact his health and well-being. Social support and resource linkage, including employment services, mental health care, and community resources, are integral to his recovery. Addressing economic stability can improve adherence to medical regimens and reduce stress, which influences overall health outcomes.
Preventive Care and Lifestyle Modifications
Preventive screenings such as lipid profiles, blood pressure monitoring, and cancer screenings should be incorporated into his routine care. Smoking cessation, substance use counseling, nutrition, regular exercise, and mental health support are essential components of holistic health management. Vaccinations, including influenza and hepatitis B, should be up-to-date.
Conclusion
Managing a transgender patient like John Green requires an interdisciplinary approach that encompasses hormonal therapy, mental health support, substance use management, HIV care, and social services. Establishing a trusting relationship, providing education, and monitoring for complications are key to improving his health outcomes. Recognizing and addressing social determinants and psychosocial factors are vital in delivering holistic, patient-centered care that aligns with his gender identity and personal needs.
References
- Bradbury-Jones, C., & Isham, L. (2020). The protective edge: Nursing, resilience, and health promotion for transgender people. Journal of Advanced Nursing, 76(4), 840–851.
- Gordon, G., & Bockting, W. (2018). Transgender health: A new frontier for integrated care. Journal of General Internal Medicine, 33(10), 1599–1603.
- Hembree, C. H., et al. (2017). Endocrine treatment of gender-dysphoric/gender-incongruent persons: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 102(11), 3869–3903.
- Klein, L., et al. (2018). Substance use and mental health disparities among transgender populations. LGBT Health, 5(2), 100–107.
- Seelman, K. L., et al. (2016). Transgender health care: Improving the quality of care and health outcomes. Journal of Transcultural Nursing, 27(3), 232–240.
- Sutton, K., et al. (2018). The importance of social determinants in health care for transgender individuals. Social Science & Medicine, 202, 148–156.
- Reisner, S. L., et al. (2016). Mental health of transgender youth in the U.S.: A systematic review. Journal of Adolescent Health, 59(4), 385–398.
- Stroumsa, D., et al. (2019). HIV care continuum among transgender women: A systematic review. AIDS and Behavior, 23(2), 324–334.
- World Professional Association for Transgender Health (WPATH). (2017). Standards of Care for the Health of Transgender and Gender Nonconforming People (7th ed.).
- Zwickl, J. L., et al. (2020). Substance use and mental health in transgender youth: A review of current research. Journal of Homosexuality, 67(2), 150–172.